There’s something to be said about business people being able to turn anything into a means of earning a profit. In the case of some establishments in China, for example, being able to offer customers clean air is considered a luxury amenity. As crazy as that may sound, it actually makes sense since the elite clients of these places do pay more for the privilege of being able to breathe without coughing smog.
It speaks to how bad things have gotten in China with regards to air pollution that when the Cordis hotel opened in Shanghai, one of its greatest selling points is having clean, indoor air, The Guardian reports. In terms of its other amenities, the hotel is hardly any different from many other luxury establishments in the city. Therefore, it’s a testament to the dire need of fresh air that people have that Cordis can stand out in this manner.
As to how the Cordis actually manages to keep its interior air so clean, this is due to the air filtration system that the builders installed. The dirty air from the outside basically has to go through two layers of filtration to be cleaned and even the air inside the hotel is constantly cycled through the filters to keep it clean.
It’s not just hotels that are getting the luxury clean air treatment either. In India, some of the most expensive schools in Delhi are offering the same amenities, Futurism notes. This basically means that only those who have the means to afford it can have air that is not as dangerous to breathe.
Everyone else will have to breathe in polluted air. This will lead to even more cases of asthma attacks, lung cancer, and cardiovascular issues that are directly linked to air pollution at the scale these countries are experiencing.


Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Tabletop particle accelerator could transform medicine and materials science
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



